Von Gierke disease

[MIM 232 200]

(Glycogen storage disease type Ia)

Prevalence: 1/100.000. Autosomal recessive transmission of a mutation of the G6PC1 gene (17q21.31) causing a deficiency in glucose-6-phosphatase in the liver, kidneys and small bowel. Early onset (first months of life).


Clinical signs:


-        hepatomegaly without splenomegaly, risk of liver adenomas and hepatomas

-        muscular hypotrophy, chubby facies

-        hypoglycemia with hyperlactacidemia; convulsions, coma, and mental retardation if medical treatment is not followed

-        short stature,

-        tendency to bleeding despite a normal or increased platelet count

-        hyperuricemia with risk of urinary lithiasis

-        hypertriglyceridemia (xanthomas)

-        nephromegaly

-        osteoporosis.


Treatments: continuous glucose intake (night gavage with starch solutions); liver transplantation.


Anesthetic implications:

Avoid prolonged fasting; check platelet function (thromboelastogram); monitor blood glucose and lactates levels. Risk of per- and postoperative hyperlactatemia even with normal blood glucose levels: the cause is probably an excess of glucose-6-phosphate being transformed into pyruvate and lactate, associated with the perioperative hormonal stress response.


One case of pancreatitis secondary to hypertriglyceridemia following a continuous infusion of propofol has been reported.


References : 


Updated: April 2025